{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T09:25:09Z","timestamp":1765185909631,"version":"3.46.0"},"reference-count":10,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"DOI":"10.2340\/actadv.v105.adv-2025-0015","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T09:22:47Z","timestamp":1765185767000},"source":"Crossref","is-referenced-by-count":0,"title":["Mantle Cell Lymphoma Presenting as a Primary Cutaneous Mass: A Case Report"],"prefix":"10.2340","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0962-5053","authenticated-orcid":false,"given":"Yuqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4296-8354","authenticated-orcid":false,"given":"Yimei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1358-4243","authenticated-orcid":false,"given":"Chang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9873-0025","authenticated-orcid":false,"given":"Yaqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1863-8769","authenticated-orcid":false,"given":"Xiaojie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"key":"134657","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB de O, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid Neoplasms. Leukemia 2022; 36: 1720\u20131748.","DOI":"10.1038\/s41375-022-01620-2"},{"key":"134658","doi-asserted-by":"crossref","unstructured":"Jain P, Wang ML. Mantle cell lymphoma in 2022 \u2013 A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments. Am J Hematol 2022; 97: 638\u2013656.","DOI":"10.1002\/ajh.26523"},{"key":"134659","doi-asserted-by":"crossref","unstructured":"Akay BN, Farabi B, Atak MF, Kuzu I, Heper AO. Cutaneous involvement of mantle cell lymphoma: report of two cases with dermatoscopic features. Dermatol Pract Concept 2022; 12: e2022064.","DOI":"10.5826\/dpc.1202a64"},{"key":"134660","doi-asserted-by":"crossref","unstructured":"Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis B, Bartlett NL, et al. NCCN guidelines\u00ae insights: B-cell lymphomas, version 6.2023. J Natl Compr Canc Netw 2023; 21: 1118\u20131131.","DOI":"10.6004\/jnccn.2023.0057"},{"key":"134661","doi-asserted-by":"crossref","unstructured":"Trutzer IM, Lossos IS. Relapsed mantle cell lymphoma manifesting with soft tissue tumors of the extremities: University of Miami experience and review of the literature. Ann Hematol 2024; 103: 4581\u20134588.","DOI":"10.1007\/s00277-024-05997-1"},{"key":"134662","doi-asserted-by":"crossref","unstructured":"Li S, Tang G, Jain P, Lin P, Xu J, Miranda RN, et al. SOX11+ large B-cell neoplasms: cyclin D1-negative blastoid\/pleomorphic mantle cell lymphoma or large B-cell lymphoma? Mod Pathol 2024; 37: 100405.","DOI":"10.1016\/j.modpat.2023.100405"},{"key":"134663","doi-asserted-by":"crossref","unstructured":"Scheubeck G, Jiang L, Hermine O, Kluin-Nelemans HC, Schmidt C, Unterhalt M, et al. Clinical outcome of mantle cell lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression). Leukemia 2023; 37: 1887\u20131894.","DOI":"10.1038\/s41375-023-01977-y"},{"key":"134664","doi-asserted-by":"crossref","unstructured":"Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, et al. Ibrutinib plus bendamustine and rituximab in untreated mantle-cell lymphoma. N Engl J Med 2022; 386: 2482\u20132494.","DOI":"10.1056\/NEJMoa2201817"},{"key":"134665","doi-asserted-by":"crossref","unstructured":"Dreyling M, Doorduijn JK, Gin\u00e9 E, Jerkeman M, Walewski J, Hutchings M, et al. Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation in previously untreated mantle cell lymphoma (TRIANGLE). Lancet 2024; 403: 2293\u20132306.","DOI":"10.1016\/S0140-6736(24)00184-3"},{"key":"134666","doi-asserted-by":"crossref","unstructured":"Song Y, Zhou K, Zou D, Zhou J, Hu J, Yang H, et al. Zanubrutinib in relapsed\/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study. Blood 2022; 139: 3148\u20133158.","DOI":"10.1182\/blood.2021014162"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45142\/52162","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45142\/52163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45142\/52164","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/45142\/52162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T09:22:50Z","timestamp":1765185770000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/45142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":10,"URL":"https:\/\/doi.org\/10.2340\/actadv.v105.adv-2025-0015","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,7]]}}}